Vir’s George Scan­gos teams up with his for­mer col­leagues at Bio­gen to press fast-for­ward on an­ti­body pro­grams for coro­n­avirus

Vir CEO George Scan­gos is in hot pur­suit of some an­ti­bod­ies that can com­bat coro­n­avirus. And he’s turned to one big shop he knows well to cov­er the man­u­fac­tur­ing end of that strat­e­gy.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER